Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
FDA proposes restricting compounding of weight-loss drugs to curb generic versions.
The FDA has proposed removing ingredients for popular weight-loss drugs from a list that allows pharmacies to compound them, aiming to restrict large-scale production of generic-like versions.
This move is expected to lower the availability of cheaper alternatives, though most personalized compounding may remain unaffected.
The agency is accepting public comments on the proposal until June 29.
7 Articles
La FDA propone restringir el compuesto de medicamentos para bajar de peso para frenar las versiones genéricas.